BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lau A, So HC. Turning genome-wide association study findings into opportunities for drug repositioning. Comput Struct Biotechnol J 2020;18:1639-50. [PMID: 32670504 DOI: 10.1016/j.csbj.2020.06.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Bell N, Uffelmann E, van Walree E, de Leeuw C, Posthuma D. Using genome-wide association results to identify drug repurposing candidates.. [DOI: 10.1101/2022.09.06.22279660] [Reference Citation Analysis]
2 Pinakhina D, Loboda A, Sergushichev A, Artomov M. GCDPipe: risk gene, cell type, and drug ranking for complex traits.. [DOI: 10.1101/2022.07.27.501775] [Reference Citation Analysis]
3 Lee C, Lin J, Prokop A, Gopalakrishnan V, Hanna RN, Papa E, Freeman A, Patel S, Yu W, Huhn M, Sheikh AS, Tan K, Sellman BR, Cohen T, Mangion J, Khan FM, Gusev Y, Shameer K. StarGazer: A Hybrid Intelligence Platform for Drug Target Prioritization and Digital Drug Repositioning Using Streamlit. Front Genet 2022;13:868015. [PMID: 35711912 DOI: 10.3389/fgene.2022.868015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Abdelsayed M, Kort EJ, Jovinge S, Mercola M. Repurposing drugs to treat cardiovascular disease in the era of precision medicine. Nat Rev Cardiol. [DOI: 10.1038/s41569-022-00717-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Arnatkevičiūtė A, Fornito A, Tong J, Pang K, Fulcher BD, Bellgrove MA. Linking GWAS to pharmacological treatments for psychiatric disorders.. [DOI: 10.1101/2022.05.11.22274981] [Reference Citation Analysis]
6 Russ D, Williams JA, Cardoso VR, Bravo-merodio L, Pendleton SC, Aziz F, Acharjee A, Gkoutos GV. Evaluating the detection ability of a range of epistasis detection methods on simulated data for pure and impure epistatic models. PLoS ONE 2022;17:e0263390. [DOI: 10.1371/journal.pone.0263390] [Reference Citation Analysis]
7 Lin WZ, Liu YC, Lee MC, Tang CT, Wu GJ, Chang YT, Chu CM, Shiau CY. From GWAS to drug screening: repurposing antipsychotics for glioblastoma. J Transl Med 2022;20:70. [PMID: 35120529 DOI: 10.1186/s12967-021-03209-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Mirza N, Stevelink R, Taweel B, Koeleman BPC, Marson AG; International League Against Epilepsy Consortium on Complex Epilepsies . Using common genetic variants to find drugs for common epilepsies. Brain Commun 2021;3:fcab287. [PMID: 34988442 DOI: 10.1093/braincomms/fcab287] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Adikusuma W, Chou W, Lin M, Ting J, Irham LM, Perwitasari DA, Chang W, Chang W. Identification of Druggable Genes for Asthma by Integrated Genomic Network Analysis. Biomedicines 2022;10:113. [DOI: 10.3390/biomedicines10010113] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
10 Farouk IA, Low ZY, Puniyamurti A, Zabidi NZ, Amin MKA, Lal SK. Genomic Approaches for Drug Repositioning. Biomedical Translational Research 2022. [DOI: 10.1007/978-981-16-9232-1_5] [Reference Citation Analysis]
11 Olla S, Steri M, Formato A, Whalen MB, Corbisiero S, Agresti C. Combining Human Genetics of Multiple Sclerosis with Oxidative Stress Phenotype for Drug Repositioning. Pharmaceutics 2021;13:2064. [PMID: 34959343 DOI: 10.3390/pharmaceutics13122064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Malacrida AM, Salci TP, Negri M, Svidzinski TI. Insight into the antifungals used to address human infection due to Trichosporon spp.: a scoping review. Future Microbiol 2021;16:1277-88. [PMID: 34689610 DOI: 10.2217/fmb-2021-0048] [Reference Citation Analysis]
13 Fadason T, Farrow S, Gokuladhas S, Golovina E, Nyaga D, O'Sullivan JM, Schierding W. Assigning function to SNPs: Considerations when interpreting genetic variation. Semin Cell Dev Biol 2021:S1084-9521(21)00220-2. [PMID: 34446357 DOI: 10.1016/j.semcdb.2021.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
14 Lu H, Zhang J, Chen YE, Garcia-Barrio MT. Integration of Transformative Platforms for the Discovery of Causative Genes in Cardiovascular Diseases. Cardiovasc Drugs Ther 2021;35:637-54. [PMID: 33856594 DOI: 10.1007/s10557-021-07175-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK, Kumar P. Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Mol Divers 2021;25:1315-60. [PMID: 33844136 DOI: 10.1007/s11030-021-10217-3] [Cited by in Crossref: 83] [Cited by in F6Publishing: 48] [Article Influence: 41.5] [Reference Citation Analysis]